Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol Succinate in Post-Acute Sequelae of COVID-19 (PEACE)
NCT05096884Phase 1Terminated
- Sponsor
- Hackensack Meridian Health
- Start
- Mar 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of metoprolol in post-COVID-19 condition (PCC), sponsored by Hackensack Meridian Health. Primary endpoints: 6 Minute Walk Test at 12 weeks and Valvuloarterial Impedance at 12 weeks. Started Mar 2022; status: terminated.
02
Drugs
metoprolol
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT05096884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096884.